Your browser doesn't support javascript.
loading
Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.
Zhou, Duanfang; Li, Xiaoli; Xiao, Xiaoqiu; Wang, Gang; Chen, Bo; Song, Yi; Liu, Xu; He, Qichen; Zhang, Huan; Wu, Qiuya; Zhang, Limei; Wu, Lihong; Shen, Zhengze; Hassan, Moustapha; Zhao, Ying; Zhou, Weiying.
Afiliação
  • Zhou D; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China; Department of pharmacy, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Li X; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China; Key laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Chongqing, China.
  • Xiao X; The Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Wang G; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Chen B; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Song Y; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Liu X; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • He Q; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Zhang H; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Wu Q; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Zhang L; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Wu L; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China.
  • Shen Z; Department of pharmacy, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
  • Hassan M; Experimental Cancer Medicine, Division of Bio-molecular and Cellular Medicine (BCM), Department of Laboratory Medicine, Karolinska Institutet, Sweden.
  • Zhao Y; Experimental Cancer Medicine, Division of Bio-molecular and Cellular Medicine (BCM), Department of Laboratory Medicine, Karolinska Institutet, Sweden.
  • Zhou W; Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Drug Metabolism, Chongqing, China; Key laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Chongqing, China. Electronic address: wyzhou0118@163.com.
Phytomedicine ; 110: 154634, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36603341
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Diabetes Mellitus Tipo 2 Tipo de estudo: Prognostic_studies Idioma: En Revista: Phytomedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Diabetes Mellitus Tipo 2 Tipo de estudo: Prognostic_studies Idioma: En Revista: Phytomedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China